Search clinical trials for: Group A: Trivalent Oral Polio Vaccine

Total 185 results

Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh; Ministry... and other collaborators

Completed

Immunogenicity of Inactivated and Live Polio Vaccines

Poliomyelitis

Bangladesh
Fidec Corporation
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention

Completed

Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine

Poliomyelitis

Colombia, Dominican Republic, Guatemala, Panama
Aga Khan University
National Institutes of Health (NIH); World Health Organization

Completed

IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. (MIPV)

Immunity to Polio Vaccines in Malnourished Infants | Immunity to Polio Vaccines in Non-malnourished Infants

Pakistan
Centers for Disease Control and Prevention
Tribhuvan University, Nepal

Completed

Diarrhea and Bivalent Oral Polio Vaccine Immunity

Diarrhea | Polio | Seroimmunity

Nepal
PATH
Centers for Disease Control and Prevention; Institut Pasteur; Institut de Recherche...

Completed

Inactivated Influenza Vaccine Effectiveness in Tropical Africa

Influenza

Senegal
Aga Khan University
World Health Organization

Completed

Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3 (SIAD)

Polio

Pakistan
PATH
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; The Emmes Company, LLC and other collaborators

Completed

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Poliomyelitis

United States
Seqirus
Novartis Vaccines

Completed

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

Influenza

Belgium
Guangxi Zhuang Autonomous Region Center for Disease...
Air Force Military Medical University, China; Beijing Tiantan Biological Products...

Completed

Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine (TTbOPV)

Poliomyelitis
PATH

Completed

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Polio

Belgium
Wayne Sullender, M.D.
All India Institute of Medical Sciences, New Delhi; Centers for Disease Control...

Completed

Direct and Indirect Protection by Influenza Vaccine Given to Children in India

Influenza

India
PT Bio Farma

Completed

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Healthy

Indonesia
CanSino Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Poliomyelitis

Australia
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
International Centre for Diarrhoeal Disease Research...
Stanford University; Centers for Disease Control and Prevention

Recruiting

Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine

Vaccine Reaction

Bangladesh
Shanghai Institute Of Biological Products

Completed

A Clinical Trial of A Quadrivalent Influenza Vaccine

Influenza

China
Jiangsu Province Centers for Disease Control and...
Jiangsu Jindike Biotechnology Co., Ltd.

Completed

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

Influenza

China
Bandim Health Project
Statens Serum Institut; Research Center for Vitamins and Vaccines

Unknown

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children (RE-CAMP)

Mortality | Children | Oral Polio Vaccine | Morbidity | Measles Vaccination | Non-specific/Heterologous Effects of Vaccines

Guinea-Bissau
Aga Khan University
Bill and Melinda Gates Foundation; World Health Organization; UNICEF; Peshawar... and other collaborators

Unknown

To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan

Polio | Polio Sero Conversion | Polio Sero Prevalence | Immunization Coverage

Pakistan
Novartis Vaccines

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age

Streptococcal Infections

South Africa
Bandim Health Project

Unknown

Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth

Healthy | Infant, Newborn

Guinea-Bissau
University Hospital, Ghent

Completed

Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults (IPV-004)

Poliomyelitis

Belgium
GlaxoSmithKline
The PATH Malaria Vaccine Initiative (MVI)

Completed

Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa

Malaria

Ghana, Kenya, Mozambique, Tanzania, Burkina Faso, Gabon, Malawi
Bandim Health Project
Radboud University Medical Center

Enrolling by invitation

The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau

Vaccine Reaction

Guinea-Bissau
Tampere University

Completed

Live Enterovirus Vaccine and Type 1 Diabetes

Type 1 Diabetes | Prediabetic State | Enterovirus Infection
Serum Institute of India Pvt. Ltd.

Completed

Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Poliomyelitis

Bangladesh
PATH
Beijing Bio-Institute Biological Products Co., Ltd., formerly Beijing TiantanBio

Completed

Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine

Poliomyelitis

Kenya
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

Poliomyelitis

Panama
Bandim Health Project

Active, not recruiting

OPV as Potential Protection Against COVID-19

Mortality | COVID | Morbidity | Poliovirus Vaccine, Oral | Non-Specific Effects of Vaccines

Guinea-Bissau
University of Maryland, Baltimore

Completed

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Risk Reduction

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen

Malaria

Ghana, Tanzania, Gabon
Sinovac Biotech Co., Ltd

Completed

Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants

Influenza

China
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort (SLVP033)

Hepatitis A | Influenza | Healthy Adults | Typhoid

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Influenza

Philippines
Instituto Nacional de Salud Publica, Mexico
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.

Withdrawn

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Influenza

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Infections

Philippines
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type b

Philippines
Roswell Park Cancer Institute

Completed

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
Beijing Minhai Biotechnology Co., Ltd

Completed

Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine

Meningitis

China
Sinovac Biotech Co., Ltd

Completed

Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

Influenza

China
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age (T2-ABMG)

Poliomyelitis
Universiteit Antwerpen
Chulalongkorn University; Thrasher Research Fund; Institut Pasteur de Lille

Completed

Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

Pertussis

Thailand
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors

Glioma | Astrocytoma | Oligodendroglioma

United States
Mahidol University
Ministry of Health, Thailand; Bhumirajanagarindra Kidney Institute, Thailand

Completed

Immune Response to Influenza Vaccine in ESRD Patients

Immunology | Nephrology
PATH
Bio Farma, Indonesia

Not yet recruiting

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Poliomyelitis

Bangladesh
Wei Cun
Yunnan Center for Disease Control and Prevention

Unknown

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

Meningitis, Meningococcal

China
Emory University
National Cancer Institute (NCI); Sanofi; National Institutes of Health (NIH)

Completed

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Plasma Cell Neoplasm

United States
University of Vermont
World Health Organization

Active, not recruiting

Intradermal Fractional Dose IPV (fIPV) in Combination With dmLT

Poliomyelitis

United States
National Cancer Institute (NCI)

Terminated

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Breast Cancer | Bladder Cancer | Colon Cancer

United States
Novartis
Novartis Vaccines

Completed

Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings

Bacterial Infection | Streptococcal Infection | Gram-positive Bacterial Infection

Belgium, Canada

Search clinical trials for: Group A: Trivalent Oral Polio Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations